Literature DB >> 16749271

Economic burden of tuberculosis in patients attending DOT centres in Delhi.

T K Ray1, N Sharma, M M Singh, G K Ingle.   

Abstract

Tuberculosis inflicts a negative impact on global socioeconomic prosperity. Though India carries one third of the global burden of the disease, few studies have focussed in the country on this aspect. The present study was therefore, framed to estimate economic loss amongst TB patients. A total of 156 patients attending two DOT centres were interviewed in depth, regarding economic loss due to tuberculosis, using a semi structured pretested interview schedule during a period of 5 months. More than 75% of the subjects belonged to the age group of 15-44 years of which 71.6% were males. 34.6% of patients were housewives and 10.9% were students. Mean expenditure before registration in DOT centre was Rs. 3385.5 irrespective of all socioeconomic classes. The upper lower socio-economic class of patients incurred maximum mean expenditure of Rs. 9782.0. Mean duration of wage loss was found to be 47.1 days. Study participants incurred economic loss both in terms of direct and indirect costs, more so in lower socio-economic group, besides delay in attending DOT centres for treatment. Awareness campaign focussing on treatment availability and DOT centre could help in reducing such economic loss.

Entities:  

Mesh:

Year:  2005        PMID: 16749271

Source DB:  PubMed          Journal:  J Commun Dis        ISSN: 0019-5138


  9 in total

1.  How much do Indians pay for tuberculosis treatment? A cost analysis.

Authors:  P Sinha; M Carwile; A Bhargava; C Cintron; C Acuna-Villaorduna; S Lakshminarayan; A F Liu; N Kulatilaka; L Locks; N S Hochberg
Journal:  Public Health Action       Date:  2020-09-21

2.  Listening to Those at the Frontline: Patient and Healthcare Personnel Perspectives on Tuberculosis Treatment Barriers and Facilitators in High TB Burden Regions of Argentina.

Authors:  Sarah J Iribarren; Fernando Rubinstein; Vilda Discacciati; Patricia F Pearce
Journal:  Tuberc Res Treat       Date:  2014-09-28

3.  Cost of illness of tuberculosis in tehran in the year 2011.

Authors:  Mojtaba Hasoumi; Mahshid Nasehi; Mehdi Khakian; Mohammad Mohseni; Hajarbibi Ziaiifar; Meysam Safi Keykale
Journal:  Mater Sociomed       Date:  2014-10-29

4.  Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India.

Authors:  Mihir P Rupani; Adithya Cattamanchi; Priya B Shete; William M Vollmer; Sanjib Basu; Jigna D Dave
Journal:  Infect Dis Poverty       Date:  2020-10-19       Impact factor: 4.520

5.  Converting and expanding mobile support tools for tuberculosis treatment support: Design recommendations from domain and design experts.

Authors:  Sarah J Iribarren; Jessica Wallingford; Rebecca Schnall; George Demiris
Journal:  J Biomed Inform X       Date:  2019-12-18

6.  Mobile Tuberculosis Treatment Support Tools to Increase Treatment Success in Patients with Tuberculosis in Argentina: Protocol for a Randomized Controlled Trial.

Authors:  Sarah Iribarren; Hannah Milligan; Kyle Goodwin; Omar Alfonso Aguilar Vidrio; Cristina Chirico; Hugo Telles; Daniela Morelli; Barry Lutz; Jennifer Sprecher; Fernando Rubinstein
Journal:  JMIR Res Protoc       Date:  2021-06-21

7.  Barriers and enablers in the management of tuberculosis treatment in Addis Ababa, Ethiopia: a qualitative study.

Authors:  Mette Sagbakken; Jan C Frich; Gunnar Bjune
Journal:  BMC Public Health       Date:  2008-01-11       Impact factor: 3.295

8.  Geographic prediction of tuberculosis clusters in Fukuoka, Japan, using the space-time scan statistic.

Authors:  Daisuke Onozuka; Akihito Hagihara
Journal:  BMC Infect Dis       Date:  2007-04-11       Impact factor: 3.090

Review 9.  Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review.

Authors:  Tadayuki Tanimura; Ernesto Jaramillo; Diana Weil; Mario Raviglione; Knut Lönnroth
Journal:  Eur Respir J       Date:  2014-02-13       Impact factor: 16.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.